Início
Mercados
Gráficos e ideias
Algo
Notícias
Store
Corretoras
Baixar
Calendário econômico
Sinais de Negociação
Terminal web
Pressione
/
para pesquisar: @user, $symbol, ...
Pesquisar
Login
Criar uma conta
Português
English
Русский
中文
Español
日本語
Deutsch
한국어
Français
Italiano
Türkçe
MIRM
#1167
Mirum Pharmaceuticals, Inc. Common Stock
92.290
0
+0.51%
Setor:
Base:
Moeda do lucro:
Faixa diária
Faixa anual
Mudança diária
+0.51%
Mudança mensal
-8.40%
Mudança em 6 meses
+31.60%
Mudança anual
+31.60%
Fechamento anterior
91.820
0
Open
92.110
0
Bid
Ask
Low
92.110
0
High
92.290
0
Volume
133
Mercados
Ações
Cuidados de saúde
MIRM
Open full chart
Financials
Overview
Relatórios
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
30.42 M
31.73 M
37.95 M
47 M
49.01 M
60.34 M
—
Valuation ratios
Enterprise value
389.04 M
474.76 M
703.69 M
1.12 B
1.8 B
4.47 B
12.3 B
Price to earnings ratio
—
—
-4.8
-7.5
-22.35
-168.06
-325.38
Price to sales ratio
—
—
8.5
6.59
5.83
7.61
26.96
Price to cash flow ratio
—
—
5.45
17.3
190.32
71.03
-261.54
Price to book ratio
—
—
4.61
4.94
8.71
12.6
21.26
Enterprise value to EBITDA ratio
—
—
—
—
—
—
—
Profitability ratios
Return on assets %
-0.43
-0.29
-0.38
-0.25
-0.13
-0.03
-0.03
Return on equity %
-0.6
-0.7
-0.96
-0.66
-0.39
-0.07
-0.09
Return on invested capital %
-2 442.39
-1 010.86
-339.27
-197.68
-125.01
-28.12
-34.74
Gross margin %
—
100
100
100
100
100
400
Operating margin %
—
-906.12
-170.28
-58.57
-26
-4.25
-22.53
EBITDA margin %
—
—
—
—
—
—
—
Net margin %
—
-438.85
-176.05
-87.68
-26.1
-4.48
-19.4
Liquidity ratios
Quick ratio
—
3.88
2.85
4.19
2.93
2.55
11.73
Current ratio
12.8
3.91
2.94
4.45
3.1
2.67
12.33
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
—
0.07
0.24
0.37
0.51
0.69
0.7
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
0.47
0.46
0.37
1.63
Long term debt to total equity ratio
—
—
—
1.23
1.37
0.98
4.58
Per share metrics
Operating cash flow per share
—
—
-3.54
-1.74
0.22
1.11
1.02
EBIT per share
—
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
—
4.46
7
5.9
7.64
26.03
Net current asset value per share
—
—
5.6
9.48
8.27
10.95
37.78
Tangible book value per share
—
—
2.44
-0.1
-0.51
1.07
2.26
Working capital per share
—
—
3.69
7.35
5.6
6.85
25.35
Book value per share
—
—
4.18
6.08
4.75
6.27
21.3
Notícias
Drug Stocks Lead Eight Hot New Names Onto IBD 50 List, Big Cap 20 And More
Leerink reduz preço-alvo das ações da Mirum Pharmaceuticals para US$ 118
Evercore ISI reitera classificação Outperform para ações da Mirum Pharmaceuticals
Leerink cuts Mirum Pharmaceuticals stock price target to $118
Evercore ISI reiterates Mirum Pharmaceuticals stock rating at Outperform
Ações da Mirum Pharmaceuticals caem com perspectiva de gastos em P&D, RBC reitera Outperform
Mirum Pharmaceuticals stock falls on R&D spending outlook, RBC reiterates Outperform
Mirum's Q4 Earnings Lag, Higher Product Sales Drive Y/Y Revenues
Mirum Pharmaceuticals: Nothing Stops This Train (But The Technicals) (NASDAQ:MIRM)
Citizens reduz preço-alvo da Mirum Pharmaceuticals por valuation
Citizens cuts Mirum Pharmaceuticals stock price target on valuation
Lucro da Mirum Pharmaceuticals veio abaixo das projeções por $0,08; receita supera estimativas